Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Non-small Cell Lung”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00004979
What this trial is testing

Topotecan and Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT03970746
What this trial is testing

Safety, Immunogenicity and Preliminary Clinical Activity Study of PDC*lung01 Cancer Vaccine in NSCLC

Who this might be right for
Non Small Cell Lung Cancer
PDC*line Pharma SAS 73
Large-scale testing (Phase 3)Study completedNCT01850303
What this trial is testing

Maintenance After Induction Chemotherapy in Elderly Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer (Squamous or Non Squamous)
Intergroupe Francophone de Cancerologie Thoracique 632
Early research (Phase 1)Active Not RecruitingNCT03546361
What this trial is testing

CCL21-Gene Modified Dendritic Cell Vaccine and Pembrolizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer

Who this might be right for
Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8Stage IVA Lung Cancer AJCC v8+1 more
Jonsson Comprehensive Cancer Center 24
Not applicableActive Not RecruitingNCT07389642
What this trial is testing

Brain Oligometastasis in NSCLC

Who this might be right for
Brain OligometastaticNon-small Cell Lung Cancer
University Hospital, Bordeaux 46
Testing effectiveness (Phase 2)Study completedNCT04181788
What this trial is testing

Sasanlimab (PF-06801591, PD-1 Inhibitor) in Participants With Advanced Malignancies

Who this might be right for
Advanced MalignanciesNon-small-cell Lung Cancer
Pfizer 155
Testing effectiveness (Phase 2)Ended earlyNCT04372927
What this trial is testing

ADMIRAL Trial: Adaptive Mediastinal Radiation With Chemo-Immunotherapy

Who this might be right for
Locally Advanced Lung Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8+2 more
University of Washington 1
Early research (Phase 1)Study completedNCT02166242
What this trial is testing

Ethaselen for the Treatment of Thioredoxin Reductase High Expression Advanced Non-small Cell Lung Cancers

Who this might be right for
Carcinoma, Non-small Cell Lung
Hunan Province Tumor Hospital 40
Testing effectiveness (Phase 2)Ended earlyNCT02382406
What this trial is testing

Carboplatin/Nab-Paclitaxel and Pembrolizumab in NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Nisha Mohindra, MD 46
Large-scale testing (Phase 3)Active Not RecruitingNCT04547504
What this trial is testing

PEmbRolizumab verSus chEmotherapy and pEmbrolizumab in Non-small-cell Lung Cancers (NSCLC) With PDL1 ≥ 50 %

Who this might be right for
Non-small-cell Lung Cancer
University Hospital, Brest 349
Early research (Phase 1)Looking for participantsNCT06066138
What this trial is testing

Therapeutic Drug Monitoring-Based Atezolizumab Dosing

Who this might be right for
Locally Advanced Alveolar Soft Part SarcomaMetastatic Alveolar Soft Part SarcomaLocally Advanced Non Small Cell Lung Cancer+7 more
National Cancer Institute (NCI) 30
Not applicableUnknownNCT00503958
What this trial is testing

Liverpool Lung Project: Risk Factors and Genetic Markers in Healthy Participants and Patients With Lung Cancer

Who this might be right for
Health Status UnknownLung Cancer
University of Liverpool Cancer Research Centre 8,300
Testing effectiveness (Phase 2)Study completedNCT01858389
What this trial is testing

Dacomitinib (PF-00299804) In Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Pfizer 41
Testing effectiveness (Phase 2)UnknownNCT05603013
What this trial is testing

Vinorelbine Metronomic Chemotherapy Combined With Hypofractionated Radiotherapy, PD-1/PD-L1 Sequential GM-CSF and IL-2 for Treatment of Advanced Refractory Non-small Cell Lung Cancer and Breast Cancer(PRaG 6.0)

Who this might be right for
Carcinoma, Non-Small-Cell LungCarcinoma Breast
Second Affiliated Hospital of Soochow University 45
Not applicableActive Not RecruitingNCT02515760
What this trial is testing

Tumor-specific T Cells in Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
University Hospital Heidelberg 120
Not applicableStudy completedNCT03926260
What this trial is testing

Early Assessment of Response to Treatment of Metastatic LUng Tumors Based on CIrculating Tumor DNA

Who this might be right for
Metastatic Non-small Cell Lung Cancer
Centre Hospitalier Departemental Vendee 100
Not applicableStudy completedNCT03643484
What this trial is testing

IMFINZI Specific-Clinical Experience Investigation in Patients With NSCLC After Definitive Chemoradiation Therapy

Who this might be right for
Carcinoma, Non-Small-Cell Lung
AstraZeneca 634
Testing effectiveness (Phase 2)Looking for participantsNCT05613452
What this trial is testing

Carbon Ion Therapy for Peripheral Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Shanghai Proton and Heavy Ion Center 43
Early research (Phase 1)Study completedNCT02197247
What this trial is testing

Study to Assess the Effect of Rifampicin on Blood Levels and Safety of AZD9291, in Patients With EGFRm+ NSCLC

Who this might be right for
Non Small Cell Lung Cancer
AstraZeneca 41
Testing effectiveness (Phase 2)Looking for participantsNCT06109558
What this trial is testing

The Efficacy and Safety of LMV-12 Combined With Osimertinib in NSCLC

Who this might be right for
Non Small Cell Lung CancerRET Gene MutationMET Amplification+1 more
Hunan Province Tumor Hospital 120
Next Page